EcoR1 Capital, LLC Quant / Systematic

CIK: 0001587114 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value ($000): $299,936 (91.9% shares, 8.1% debt)

Holdings (25)

ATARA BIOTHERAPEUTICS 18.7%
Value ($000) $56,094 Shares 1,063,189 Est. Cost $36.04 Unrealized
EPIZYME 13.5%
Value ($000) $40,459 Shares 1,685,800 Est. Cost $19.11 Unrealized
ASSEMBLY BIOSCIENCES 10.1%
Value ($000) $30,317 Shares 1,574,107 Est. Cost $9.79 Unrealized
FIBROGEN 9.4%
Value ($000) $28,327 Shares 1,205,391 Est. Cost $24.77 Unrealized
ARRAY BIOPHARMA SR CONV NT 3.000% Due 06/01/2020 8.1%
Value ($000) $24,240 Shares 19,200,000 Est. Cost $0.96 Unrealized
KITE PHARMA 5.7%
Value ($000) $17,157 Shares 281,400 Est. Cost $57.67 Unrealized
FLEX PHARMA 5.2%
Value ($000) $15,629 Shares 908,691 Est. Cost $19.33 Unrealized
ATYR PHARMA 5.2%
Value ($000) $15,499 Shares 836,860 Est. Cost $18.52 Unrealized
RETROPHIN 3.8%
Value ($000) $11,326 Shares 341,650 Est. Cost $23.96 Unrealized
KINDRED BIOSCIENCES 2.9%
Value ($000) $8,828 Shares 1,294,431 Est. Cost $7.45 Unrealized
COLL COLLEGIUM PHARMACEUTICAL 2.8%
Value ($000) $8,298 Shares 465,118 Est. Cost $17.29 Unrealized 0.0%
ARRAY BIOPHARMA 2.6%
Value ($000) $7,931 Shares 11,000 Est. Cost Unrealized
OVASCIENCE 2.2%
Value ($000) $6,654 Shares 2,300 Est. Cost Unrealized
FORWARD PHARMA A/S SPONSORED ADR 2.0%
Value ($000) $6,049 Shares 158,985 Est. Cost $23.61 Unrealized
GENVEC 1.4%
Value ($000) $4,052 Shares 1,986,413 Est. Cost $2.08 Unrealized
CELLADON 1.2%
Value ($000) $3,582 Shares 2,843,170 Est. Cost $1.26 Unrealized
CALITHERA BIOSCIENCES 1.0%
Value ($000) $2,967 Shares 415,480 Est. Cost $15.57 Unrealized
ARRAY BIOPHARMA 1.0%
Value ($000) $2,884 Shares 400,000 Est. Cost $7.21 Unrealized
BIOTIE THERAPIES OYJ SPONSORED ADR 0.7%
Value ($000) $1,997 Shares 100,000 Est. Cost $19.97 Unrealized
TARGACEPT 0.6%
Value ($000) $1,729 Shares 619,699 Est. Cost $2.63 Unrealized
SERES THERAPEUTICS 0.6%
Value ($000) $1,660 Shares 40,000 Est. Cost $41.50 Unrealized
QLT 0.6%
Value ($000) $1,652 Shares 400,000 Est. Cost $4.13 Unrealized
REGULUS THERAPEUTICS 0.5%
Value ($000) $1,403 Shares 1,280 Est. Cost Unrealized
XENE XENON PHARMACEUTICALS 0.3%
Value ($000) $842 Shares 73,000 Est. Cost $14.68 Unrealized -5.8%
EPIZYME 0.1%
Value ($000) $360 Shares 150 Est. Cost Unrealized